Is oral nystatin safe for use during breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Nystatin is Safe During Breastfeeding

Oral nystatin is safe to use while breastfeeding, as it is poorly absorbed systemically and poses minimal risk to the nursing infant.

Key Evidence from FDA Labeling

The FDA drug label for oral nystatin states that "it is not known whether nystatin is excreted in human milk" but recommends caution when administered to nursing women 1. However, this conservative language reflects the lack of formal studies rather than evidence of harm.

Why Nystatin is Safe During Lactation

The pharmacokinetic properties of oral nystatin make it extremely unlikely to affect a breastfed infant:

  • Nystatin is poorly absorbed from the gastrointestinal tract when taken orally 1
  • With minimal systemic absorption in the mother, there is negligible transfer into breast milk
  • Even if trace amounts entered breast milk, the infant would not absorb it systemically from their own GI tract

Clinical Practice Supports Use

Nystatin is commonly used in breastfeeding dyads for treating thrush:

  • Oral nystatin for the infant combined with topical nystatin cream for the mother's breasts is the most common initial treatment approach for candidiasis in breastfeeding pairs 2
  • This practice pattern among lactation experts demonstrates real-world confidence in its safety profile

Practical Recommendations

When prescribing oral nystatin to a breastfeeding mother:

  • Continue breastfeeding without interruption - no need to pump and dump
  • The medication can be used for standard treatment durations without concern
  • Monitor the infant for any unusual symptoms (though adverse effects are not expected)
  • Doses up to 5 million units daily have only caused maternal GI upset, with no serious toxic effects reported 1

The theoretical risk is extremely low, and the benefits of treating maternal oral candidiasis while maintaining breastfeeding far outweigh any minimal concerns.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.